CION Ameerpet
Hyderabad's Multidisciplinary Colorectal Cancer Team
Advanced colon cancer treatment in Hyderabad — NCCN protocols, minimally invasive colectomy, MSI-guided immunotherapy.
The same NCCN guidelines used at Memorial Sloan Kettering and MD Anderson — applied by a panel of surgical oncologists, medical oncologists, radiation oncologists, gastroenterologists and pathologists working as one team. Diagnostics, laparoscopic colectomy, chemotherapy, targeted & immunotherapy and radiation are delivered in-house. Robotic surgery and HIPEC are coordinated through accredited partner centres.
- Full molecular workup — MSI/MMR, KRAS, NRAS, BRAF, HER2, NTRK in selected cases
- All colorectal resections covered — right/left hemicolectomy, sigmoid, low anterior resection, APR + stoma care
- Free 30-min consultation + free written second opinion (worth ₹950)
- Written treatment plan + cost estimate before anything starts — no surprises
17+
Cancer Specialists
on Panel
on Panel
NCCN
American-grade
Protocols
Protocols
15,000+
Patients Treated
Across Network
Across Network
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
CION cancer care is closer than you think.
9 Centres in Hyderabad · Pick yours
We're never more than 30 minutes away. Same panel of colorectal specialists at every centre. Same tumour board reviews. Same NCCN protocols. Diagnostic colonoscopy, day-care chemotherapy and follow-up happen at the centre nearest you; complex laparoscopic colectomy, radiation and HIPEC referrals run from our flagship and partner centres.
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Help me pick the right centre →
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for colon cancer surgery or chemotherapy? We may have a centre right where you are. Multi-day visits planned end-to-end. Accommodation tie-ups (₹500–1,500/night). Tele-follow-ups so you don't drive 6 hours for a 15-minute review. Local lab work-up and post-surgery wound checks coordinated where possible.
Telangana
Andhra Pradesh
Don't see your city? Call 1800 202 8726 — we'll arrange the closest pathway.
17+ senior cancer specialists. One panel for your case.
Meet The Colorectal Cancer Specialists
Trained at AIIMS, Tata Memorial, Adyar Cancer Institute and leading international centres. Combined 150+ years of experience. Every new colon-cancer case is reviewed by our surgical oncologist, medical oncologist and pathologist — together.
Surgical lead · AIIMS
Dr. Muralidhar Muddusetty
Surgical Oncologist — Colorectal & GI
MBBS (AIIMS), MS Surgery (AIIMS), DNB (Surg Onc), MRCS (Edinburgh)
Colorectal panel
Dr. Mohammed Imaduddin
Surgical Oncologist — Laparoscopic Colectomy
MBBS, MS (Gen Surg), M.Ch (Surg Onc)
Colorectal panel
Dr. Vinay Mamidala
Surgical Oncologist — Minimally Invasive Colectomy
MBBS, MS (Gen Surg), M.Ch (Surg Onc), FMAS, FARIS (Ongoing)
Colorectal panel
Dr. Vajja Sandeep Kumar
Surgical Oncologist — GI & Colorectal
MBBS, MS (Gen Surg), DrNB (Surg Onc), FALS Oncology
Colorectal panel
Dr. Sridhar Kamani
Surgical Oncologist — GI & Colorectal
MBBS, MS (Gen Surg), DrNB (Surg Onc)
Female specialist
Dr. Paila Gowri Naidu
Surgical Oncologist — GI & Colorectal
MBBS, MS (Gen Surg), M.Ch (Surg Onc), FMAS
Colorectal panel
Dr. Raghavendra Naik
Surgical Oncologist
MBBS, MS (Gen Surg), M.Ch (Surg Onc)
Adjuvant chemo lead
Dr. C. Raghavendra Reddy
Medical Oncologist — FOLFOX/CAPOX/FOLFIRI
MBBS (Gold Medal), DNB (Gen. Medicine), DM (Medical Oncology) (Gold Medal)
Medical onc panel
Dr. Naresh Gundu
Medical Oncologist — Solid tumours & GI
MBBS, DNB (Internal Medicine), DM (Medical Oncology)
Female specialist
Dr. Bharati Devi Gorantla
Medical Oncologist — Chemo / Targeted / Immunotherapy
MBBS, MD (Gen. Med), DM (Medical Oncology) (Adyar), ECMO, MRCP SCE (UK)
Medical onc panel
Dr. Owais Mohammed
Medical Oncologist — Chemo / Immunotherapy
MBBS, MD (Gen. Med), DrNB (Medical Oncology), ECMO, MRCP SCE (UK)
Female specialist
Dr. N. Kiranmayee
Medical Oncologist
MBBS, DM (Medical Oncology), MD (Internal Medicine)
Rectal pathway
Dr. Venkata Sushma P
Radiation Oncologist — IMRT/IGRT
MBBS, MD (Radiation Oncology)
Rectal pathway
Dr. Kirti Ranjan Mohanty
Radiation Oncologist — Neoadjuvant CRT
MBBS, MD (Radiation Oncology)
Rectal pathway
Dr. Gangadhar Vajrala
Radiation Oncologist
MBBS, MD (Radiation Oncology), MPH
Want a specific surgeon or medical oncologist? Mention them when booking — every case still goes through tumour board first. Book free consultation →
A new colon cancer diagnosis is overwhelming. We can take the first step with you.
Share a few details and a colorectal-cancer coordinator (not a call-centre) will call back within 30 minutes during working hours, or first thing next morning. No commitment. No pressure. Just clear answers about what's next.
Did you know?
In India, nearly 1 in 4 colon cancer diagnoses now occur in patients under 50 — a sharp shift from a decade ago. NCCN guidelines have moved the screening-start age to 45. If you have persistent bowel-habit change, blood in stool or unexplained iron-deficiency anaemia — don't wait for your 50s to investigate.
What to watch for
Colon cancer symptoms — the ones that matter
Most early colon cancers cause no symptoms at all — they are picked up on screening colonoscopy. By the time symptoms appear, the cancer is usually at least Stage I or II. Don't wait for severe symptoms.
Persistent change in bowel habit — diarrhoea, constipation, or a feeling that the bowel doesn't empty fully, lasting more than 2–3 weeks. New-onset, unexplained, and not linked to a diet change is the warning combination.
Blood in stool — bright red blood with a bowel movement is most commonly from haemorrhoids or anal fissures, but persistent bleeding, dark/maroon blood, or blood mixed into stool needs colonoscopy. Iron-deficiency anaemia in any man, or in a post-menopausal woman, is colon cancer until proven otherwise.
Narrower stools — "pencil-thin" or ribbon-like stools persisting for weeks can indicate a partially obstructing tumour, especially in the descending or sigmoid colon.
Unexplained weight loss, persistent abdominal cramping, bloating, or fatigue — non-specific by themselves, but in combination they raise the index of suspicion.
Right-sided vs. left-sided — right-sided colon cancers tend to bleed slowly (causing anaemia and fatigue without obvious bleeding) and present later. Left-sided and sigmoid cancers cause obstruction, narrowing of stool, and visible bleeding earlier.
Red-flag urgent signs: sudden severe abdominal pain with vomiting (possible obstruction), heavy rectal bleeding, or visible swelling in the abdomen — go to the nearest emergency room. Call us afterward at 1800 202 8726 for follow-up planning.
Who's at higher risk
Colon cancer risk factors — modifiable & non-modifiable
Age, family history, genetics
- Age over 45 (screening age now lowered from 50)
- First-degree relative with colon cancer or advanced polyps
- Lynch syndrome (HNPCC) — 50–80% lifetime risk
- FAP (Familial Adenomatous Polyposis) — near-100% risk if untreated
- African or South-Asian descent (slightly higher rate)
Pre-existing conditions
- Inflammatory bowel disease (Crohn's, ulcerative colitis) > 8 years
- Previous colon polyps — especially adenomas > 1 cm
- Type-2 diabetes
- Personal history of any cancer (radiation exposure, chemotherapy)
- Chronic constipation
What you can change
- High red & processed meat intake
- Low fibre, low fruit/vegetable diet
- Sedentary lifestyle, BMI > 30
- Smoking (1.2–1.5× risk)
- Heavy alcohol (> 4 drinks/day)
Reduce your risk by 30–60%
- Screening colonoscopy at 45 (or earlier if family history)
- 30 min of moderate exercise, 5×/week
- Mediterranean-style diet, low processed meat
- Aspirin (only after discussing with a doctor)
- Treat IBD aggressively; surveillance colonoscopy 1–2 yearly
Colonoscopy doesn't just detect cancer — it prevents it.
Most colon cancers begin as a small polyp that grows silently for 5–10 years. A screening colonoscopy can find and remove that polyp in the same procedure — eliminating the cancer before it ever forms. One 30-minute test, every 10 years (or 1–3 years if polyps are found), cuts colon-cancer death rates by up to 60%.
Histology matters
Types of colon & rectal cancer — and why the type changes the plan
"Colon cancer" is shorthand for several histologically distinct cancers. They share screening tools and surgery principles, but chemotherapy choices, targeted-therapy eligibility and prognosis differ.
Adenocarcinoma
Cancer of the glandular cells lining the colon and rectum. This is what most people mean when they say "colon cancer". Includes mucinous and signet-ring variants.
- Surgery + adjuvant chemo (FOLFOX/CAPOX)
- Anti-EGFR if RAS-wild type
- Immunotherapy if MSI-H/dMMR
Carcinoid (NET) of colon & rectum
Slow-growing neuroendocrine tumours. Most small rectal NETs (< 1 cm) are cured by endoscopic removal alone. Larger or metastatic NETs need a different protocol.
- Endoscopic / surgical resection
- Somatostatin analogues
- PRRT (Lu-177 DOTATATE) via partner pathway
GIST of colon
Rare in colon (more common in stomach/small bowel). Driven by KIT or PDGFRA mutations — responds dramatically to targeted therapy (imatinib).
- Surgical resection if localised
- Imatinib (Gleevec) for advanced/metastatic
- Sunitinib / regorafenib for second line
Colorectal lymphoma
Lymphoma can rarely involve the colon. Treated like nodal lymphoma — rituximab-based chemo (R-CHOP) rather than colorectal protocols. Diagnosis confirmed by biopsy + flow cytometry.
- R-CHOP or equivalent
- Surgery only for complications
- Hematology-oncology referral
Right-sided vs. left-sided
Right-sided (caecum, ascending) cancers have different biology — more often MSI-H, BRAF-mutated, mucinous. Left-sided (descending, sigmoid, rectum) cancers more often benefit from anti-EGFR therapy. Different prognosis, different drug choices.
Rectal cancer — own pathway
Anything in the lower 15 cm of bowel. Needs MRI-rectum staging and almost always benefits from neoadjuvant chemoradiation before surgery. Total mesorectal excision (TME) is the surgical standard. Watch-and-wait protocols for complete responders are now an option in select cases.
How we get to a clean diagnosis
The 7-step colon cancer diagnosis ladder
Every test serves a purpose. We don't skip rungs, and we don't add tests that don't change the plan.
1
History + physical (incl. DRE)
Symptoms, family history, drug list, comorbidities. Digital rectal examination for any rectal-bleeding presentation. Free at first consultation.
2
Colonoscopy + biopsy
The gold standard. Full visual inspection of all 6 feet of colon, biopsy of any suspicious lesion, polypectomy of removable polyps. Day-care under sedation. ₹6,000–₹15,000 in Hyderabad.
3
Histopathology & CEA baseline
Biopsy slides re-read by our colorectal pathologist. Adenocarcinoma confirmed, grade assigned, lymphovascular invasion noted. Serum CEA tested as a baseline tumour marker (not diagnostic alone).
4
CT abdomen + pelvis + chest (staging)
To check liver, lung, peritoneum, distant nodes. CT colonography only when full colonoscopy isn't possible. ₹5,000–₹12,000.
5
MRI rectum (rectal cancer only)
For any cancer in the lower 15 cm. Defines T-stage, mesorectal fascia involvement, sphincter relationship — decides surgery type and whether neoadjuvant CRT is needed. ₹8,000–₹15,000.
6
Molecular profiling — MSI/MMR + RAS + BRAF + HER2
Tells us whether immunotherapy is an option (MSI-H), whether anti-EGFR drugs will work (RAS-wildtype), whether BRAF combination is needed, and whether HER2 is targetable. Also flags Lynch syndrome. ₹15,000–₹60,000.
7
PET-CT (selective use)
Not routine for early colon cancer. Reserved for unclear CT findings, suspected metastasis, rising CEA, or planning oligometastatic resection. ₹15,000–₹25,000.
Staging & Plan
Stage-wise plan and honest 5-year outlook
Survival numbers below assume NCCN-grade care at a centre with adequate volume, full molecular workup and adjuvant therapy completed on time. They are population averages — your individual outlook depends on tumour biology, fitness and response.
| Stage | What it means | Typical plan | 5-yr outlook (NCCN-grade care) |
|---|---|---|---|
| Stage 0 (Tis) | Carcinoma in situ — cancer confined to the innermost lining of the colon. | Endoscopic polypectomy or EMR. No chemo. Surveillance colonoscopy. | > 95% |
| Stage I (T1–T2) | Cancer grown into bowel wall but not through it. No lymph node spread. | Laparoscopic colectomy. No adjuvant chemo unless high-risk features. | 90–95% |
| Stage IIA–IIC | Cancer through bowel wall but no lymph node involvement. | Colectomy. Adjuvant chemo (CAPOX or 5-FU) considered if high-risk: T4, perforation, < 12 nodes harvested, lymphovascular invasion, MSS biology. | 70–85% |
| Stage IIIA–IIIC | Cancer has spread to regional lymph nodes but not to distant organs. | Colectomy + adjuvant CAPOX/FOLFOX × 3–6 months. Duration depends on TNM substage. | 60–80% (IIIA highest, IIIC lowest) |
| Stage IVa (oligomet) | Limited liver-only or lung-only metastases that can be removed. | Multimodal — conversion chemo + targeted therapy → liver/lung resection + colon surgery. RFA / SBRT where appropriate. | 30–50% |
| Stage IVb–IVc | Widespread distant metastases (multiple organs, peritoneum, distant nodes). | Systemic therapy — chemo + targeted (anti-EGFR if RAS-WT, anti-VEGF) + immunotherapy if MSI-H. HIPEC for peritoneal-only disease (PCI ≤ 20) in fit patients via partner pathway. | 15–25% overall; significantly higher in selected subgroups |
Survival data based on NCCN v2.2026 reported outcomes. Individual outlook varies — discussed in writing at consultation.
All five modalities, one team
Colon cancer treatment modalities at CION
The right plan combines two or more of these. Surgery alone for Stage 0–I. Surgery + adjuvant chemo for Stage II–III. Combination of all five for Stage IV.
Surgery (curative-intent)
Laparoscopic colectomy is the backbone of cure for non-metastatic colon cancer. Right hemicolectomy, left hemicolectomy, sigmoid resection, low anterior resection (TME) and APR with permanent colostomy where unavoidable. ≥ 12 lymph nodes harvested as a quality marker.
Chemotherapy
FOLFOX (5-FU + leucovorin + oxaliplatin), CAPOX (capecitabine + oxaliplatin), FOLFIRI (irinotecan-based), FOLFOXIRI (triplet). Neoadjuvant for borderline-resectable disease; adjuvant for Stage III and high-risk Stage II; palliative for Stage IV. Day-care delivery at every centre.
Targeted therapy
Anti-EGFR (cetuximab, panitumumab) for RAS-wildtype left-sided tumours. Anti-VEGF (bevacizumab) added to chemo backbone. BRAF combo (encorafenib + cetuximab) for BRAF-V600E. HER2-targeted (trastuzumab + pertuzumab / tucatinib) for HER2-amplified disease.
Immunotherapy
Pembrolizumab and nivolumab for MSI-high / dMMR tumours — game-changing response rates of 40–60% in this subgroup. Now NCCN-recommended as first-line in metastatic MSI-H colon cancer. Watch for immune-related adverse events.
Radiation therapy
Rectal cancer (not colon) is the main radiation indication — neoadjuvant short-course (5 × 5 Gy) or long-course chemoradiation (50.4 Gy + capecitabine) to shrink tumour before surgery. IMRT/IGRT delivered in-house at CION radiation centres. Total Neoadjuvant Therapy (TNT) increasingly the preferred sequence.
HIPEC (partner pathway)
Cytoreductive surgery + Hyperthermic Intraperitoneal Chemotherapy for peritoneal-only metastases in fit patients with PCI ≤ 20. Eligibility decided at tumour board; delivered via accredited partner CRS-HIPEC centres in Hyderabad. Long, complex surgery with meaningful survival benefit in the right patient.
What surgery actually looks like
Colectomy types — and the recovery you should expect
- Polypectomy / EMR — done at colonoscopy. No incision. Stage 0 / very early T1 cancers. Same-day discharge.
- Right hemicolectomy — for caecal & ascending colon cancers. Laparoscopic in most cases. 4–5 day stay. Reconnection in same surgery, no stoma.
- Left hemicolectomy / sigmoid resection — for descending & sigmoid colon. Laparoscopic. 4–6 day stay. Usually no permanent stoma.
- Low anterior resection (LAR) — for upper & mid rectal cancers. Total mesorectal excision (TME) is the standard. Often a temporary diverting ileostomy that's reversed at 8–12 weeks.
- Abdominoperineal resection (APR) — for very low rectal cancers involving the sphincter. Permanent end-colostomy. Stoma-care training included in the pathway.
- Robotic colectomy (partner) — da Vinci platform for low rectal cancers where nerve preservation is critical. Slightly longer operating time, similar oncological outcomes, faster bowel-function recovery in selected patients.
Hospital stay: 3–7 days · Return to light activity: 2–3 weeks · Full recovery: 6–8 weeks · Adjuvant chemo start: 4–8 weeks post-op if indicated.
Up to date as of 2026
What's new in colon cancer treatment
Every protocol below is currently available to CION patients — in-house or via accredited partner pathway. Asked about, not glossed over.
Immunotherapy in MSI-H metastatic colon cancer
Pembrolizumab is now NCCN first-line for MSI-high/dMMR metastatic disease, replacing chemo in many patients. Median PFS > 16 months vs. 8 with chemo. 5-year survival rates dramatically higher in responders. MSI testing is mandatory before first-line decision.
BRAF-V600E combination therapy
Encorafenib + cetuximab for BRAF-mutated metastatic colon cancer — previously the worst-prognosis subgroup. Median survival improved from 5 to 9+ months in BEACON-CRC. Add binimetinib in select cases.
Organ preservation in rectal cancer
Total Neoadjuvant Therapy (TNT) — full chemo + radiation before surgery — produces complete clinical responses in 25–35% of rectal cancers. Selected complete responders can avoid surgery entirely with intensive surveillance.
HER2-targeted therapy
Trastuzumab + pertuzumab (or trastuzumab + tucatinib) for HER2-amplified RAS-wildtype metastatic colon cancer. Adds a meaningful new option for ~3–5% of patients — HER2 testing now part of our standard panel.
Circulating tumour DNA to guide adjuvant chemo
Post-surgery ctDNA testing (Signatera-style assays) identifies patients with minimal residual disease who genuinely need adjuvant chemo — and patients who do not. Increasingly available in India via reference labs. Discussed at tumour board.
Cytoreduction + HIPEC for peritoneal disease
Stage IVc peritoneal-only colon cancer with PCI ≤ 20 in fit patients — median survival doubled vs. chemo alone. CION refers to accredited Hyderabad CRS-HIPEC centres after tumour board sign-off; we run follow-up locally.
Lynch syndrome — the family conversation no one starts.
About 3–5% of colon cancers are caused by Lynch syndrome — an inherited gene change that gives carriers a 50–80% lifetime risk of colon cancer and high risks of endometrial, ovarian and other cancers. Every CION patient with MSI-H tumour or under 50 at diagnosis is offered free genetic counselling. Testing a single family member can protect 10 others.
No surprise bills
Colon cancer treatment cost in Hyderabad — written estimate before you start
Real cost ranges from the CION network for 2026. Variations come from stage, surgery type, drug choice, hospital category, and insurance pathway. You always receive a modality-wise written estimate before signing consent.
| Treatment step | Approximate range (INR) | What changes the price |
|---|---|---|
| Diagnostic colonoscopy + biopsy | ₹6,000 – ₹15,000 | Sedation, polypectomy if needed, anaesthetist fees |
| Staging CT (abdomen + pelvis + chest) | ₹5,000 – ₹12,000 | Single vs. triphasic, contrast, hospital tier |
| MRI rectum (for rectal cancer) | ₹8,000 – ₹15,000 | Tesla strength, contrast, radiologist experience |
| PET-CT (selective) | ₹15,000 – ₹25,000 | Standard FDG vs. dual-tracer |
| Molecular profiling (MSI/MMR + RAS + BRAF + HER2) | ₹15,000 – ₹60,000 | Single-gene vs. comprehensive panel |
| Laparoscopic colectomy (right / left / sigmoid) | ₹1,80,000 – ₹3,50,000 | Hospital tier, room category, anaesthesia, length of stay |
| Low anterior resection / APR (rectal) | ₹2,50,000 – ₹4,50,000 | Complexity, TME quality, stoma management, ICU need |
| Robotic colectomy (partner pathway) | ₹3,50,000 – ₹6,00,000 | Robot console use, hospital tier |
| Adjuvant chemotherapy (per cycle — FOLFOX/CAPOX) | ₹15,000 – ₹45,000 | Drug brand (generic vs. innovator), supportive meds, day-care |
| Adjuvant chemo — full 6-month course | ₹1,80,000 – ₹4,50,000 | CAPOX 8 cycles vs. FOLFOX 12 cycles, port costs |
| Targeted therapy (cetuximab / bevacizumab) per cycle | ₹35,000 – ₹1,20,000 | Body weight, brand, patient-assistance programmes |
| Immunotherapy (pembrolizumab) per cycle | ₹1,20,000 – ₹2,75,000 | Brand, cycle interval (3-weekly vs. 6-weekly) |
| Neoadjuvant chemoradiation (rectal) | ₹2,00,000 – ₹3,50,000 | IMRT planning, 28 fractions, capecitabine duration |
| CRS + HIPEC (partner pathway) | ₹4,00,000 – ₹8,00,000 | PCI score, hospital, ICU duration, blood products |
Insurance reality check: Most cashless TPAs cover ~70–90% of inpatient surgical costs and inpatient chemo cycles. Day-care chemo, targeted therapy, immunotherapy and molecular tests vary by plan. ArogyaSri covers most colon cancer surgeries and chemo for eligible families. We pre-verify your plan before quoting your out-of-pocket figure.
Cashless & Government schemes
Insurance, ArogyaSri & financial assistance
Cashless insurance partners
Government schemes & patient assistance
How decisions get made
Multidisciplinary tumour board — one panel, one plan
Every new colon-cancer diagnosis is reviewed by 4–6 specialists together, not by a single doctor. NCCN guidelines applied case-by-case, not as a recipe.
- Surgical Oncologist — operability, surgical approach, extent of resection, stoma planning.
- Medical Oncologist — neoadjuvant or adjuvant chemo regimen, targeted-therapy eligibility, immunotherapy candidacy.
- Radiation Oncologist — neoadjuvant CRT for rectal cancer, palliative radiation for bone/brain metastases.
- Pathologist — re-reads slides, confirms grade, lymphovascular invasion, margins, mismatch-repair IHC.
- Gastroenterologist — colonoscopy quality, polyp characteristics, IBD context, surveillance schedule.
- Genetic counsellor — Lynch screening, family cascade testing for first-degree relatives.
Free, written, no pressure
Second opinion — what it looks like, day-by-day
You don't need to commit to treatment with us. Records returned even if you proceed elsewhere.
Day 0
Upload reports, slides & CT via WhatsApp or in person at the closest centre.
Day 1–2
Slides re-read by our pathologist. CT re-read by our radiologist. Missing tests flagged.
Day 3–5
Molecular profiling run if not already done. Tumour board prepares your case.
Day 5–7
Panel reviews your case at multidisciplinary tumour board. Recommendation drafted in writing.
Day 7–10
You receive a written second opinion — diagnosis confirmation, recommended plan, cost estimate, and "what changes" if you go elsewhere.
No fee. No pressure. Start a free second opinion →
Real stories. Real voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements. Real patients, on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Successful Surgery & Chemo
Carcinoma of Caecum (right-sided colon)
Successful Chemo & Surgery
Dr. Imaduddin, Dr. Vinay, Dr. Owais
Surgery + Chemo + Radiation
Multimodal pathway
Successful Chemotherapy
Dr. C. Raghavendra Reddy
Successful Chemo & Surgery
Dr. Imad, Dr. Vinay, Dr. Owais
Successful Chemo & Surgery
Dr. Owais & Dr. Imaduddin
Successful Chemotherapy
Dr. Gundu Naresh
Successful Chemotherapy
Dr. Bharati Devi Gorantla
Read all 800+ reviews on Google.
What we will & won't do
Our promises — and our refusals
What we will do
- Discuss your case at multidisciplinary tumour board before any major decision
- Give you a written plan + cost estimate before you sign anything
- Test for MSI/MMR and RAS/BRAF before first-line metastatic decision
- Refer for HIPEC or robotic surgery when the evidence supports it
- Tell you honestly when a treatment won't help — and what will
- Return your records if you choose to be treated elsewhere
- Apply to patient-assistance programmes on your behalf when eligible
What we won't do
- Rush you into surgery the same day you walk in (except for true emergencies)
- Recommend a treatment without MSI/RAS testing in metastatic disease
- Pressure you to start treatment if a second opinion makes sense
- Upgrade you to robotic surgery if laparoscopic gives the same outcome
- Hide chemo toxicities or the realistic chance of cure
- Bill you for tests we never ordered or drugs you never received
- Sell "alternative cures" that have no evidence base
Not sure where to start? We'll call you.
Most callers from this page are family members reaching out for a parent or spouse. A colorectal-cancer coordinator (not a call-centre) calls back in 30 minutes during working hours.
Call 1800 202 8726What happens next
From your first call to your first treatment
1
You call or fill the form
A coordinator (not a call-centre) calls back within 30 min during working hours.
2
Records review
Send colonoscopy, biopsy, CT, blood reports via WhatsApp or e-mail. We re-read in-house.
3
First consultation (free)
30-minute appointment with the relevant surgical or medical oncologist at the closest centre.
4
Workup completed
Missing tests (molecular, MRI rectum, PET) arranged and turned around in 5–7 working days.
5
Tumour board review
Your case discussed by 4–6 specialists together. Written plan + cost estimate generated.
6
Treatment starts
Surgery scheduled within 2–3 weeks. Chemo cycle 1 within 4–8 weeks of surgery if adjuvant therapy is indicated.
FAQs
Frequently asked questions about colon cancer treatment in Hyderabad
What is the best treatment for colon cancer in Hyderabad?
There is no single best treatment — the right plan depends on tumour location (right colon, left colon, sigmoid, rectum), stage (0–IV), molecular profile (MSI/MMR, KRAS/NRAS/BRAF, HER2), patient fitness and prior treatment. At CION, every new colon-cancer diagnosis is reviewed by a multidisciplinary tumour board — surgical oncologist, medical oncologist, radiation oncologist, gastroenterologist and pathologist — so the plan reflects current NCCN guidance, not one doctor's preference. Surgery, chemotherapy, targeted therapy, immunotherapy and radiation are coordinated under one roof; HIPEC and robotic surgery are delivered via accredited partner pathways.
How much does colon cancer treatment cost in Hyderabad?
Diagnostic workup (colonoscopy + biopsy + CT + CEA + molecular profiling) typically runs ₹25,000–₹1,20,000. Laparoscopic colectomy ranges ₹1,80,000–₹4,50,000 depending on extent; open colectomy is lower, robotic is higher. A FOLFOX/CAPOX adjuvant chemotherapy cycle is ₹15,000–₹45,000 (typically 8–12 cycles). Targeted therapies (cetuximab, bevacizumab, panitumumab) and immunotherapy (pembrolizumab for MSI-H) are quoted separately and many have patient-assistance programmes. HIPEC via partner pathway is ₹4–8 lakh. You receive a written, modality-wise estimate before anything starts.
What is the difference between colon cancer and colorectal cancer?
Colon cancer arises in the colon — the longest part of the large intestine. Rectal cancer starts in the rectum — the last 15 cm before the anus. The two are often grouped together as colorectal cancer because they share most risk factors, screening tools (colonoscopy) and adjuvant chemotherapy regimens. They differ mainly in surgical approach and the role of radiation: rectal cancer often needs neoadjuvant chemoradiation; colon cancer usually does not. CION treats both.
Is robotic or laparoscopic colon cancer surgery available at CION?
Yes. Laparoscopic colectomy (right hemicolectomy, left hemicolectomy, sigmoid, low anterior resection, APR) is offered in-house at CION centres with surgical-oncology infrastructure. Robotic-assisted colectomy is delivered through accredited partner hospitals on referral when it offers a clear oncological or recovery advantage — typically for low rectal cancers requiring nerve preservation. Open surgery remains the right choice in select advanced cases. The choice is panel-driven, not technology-driven.
What is HIPEC and when is it used in colon cancer?
HIPEC stands for Hyperthermic Intraperitoneal Chemotherapy. It is delivered after cytoreductive surgery (CRS) — the surgeon removes all visible tumour, then heated chemotherapy is circulated inside the abdomen for 60–90 minutes to kill microscopic disease. HIPEC is used for colon cancer with peritoneal-only spread (Stage IVc with PCI ≤ 20), in carefully selected fit patients. At CION, eligibility is assessed at tumour board and the procedure is delivered via accredited partner centres with dedicated CRS-HIPEC teams.
What molecular tests should be done before starting colon cancer treatment?
At minimum: MSI (microsatellite instability) and MMR (mismatch repair) — these determine immunotherapy eligibility and screen for Lynch syndrome. RAS family (KRAS, NRAS) and BRAF — these determine whether anti-EGFR drugs (cetuximab, panitumumab) will work, and identify BRAF-V600E mutation for combination therapy. HER2 in metastatic disease — opens HER2-targeted options. NTRK fusion in selected cases. CION runs all of these in-house or through accredited reference labs; results are typically available in 7–10 days and are factored into the written plan.
Can colon cancer be cured?
For most early-stage colon cancer, yes. Stage 0 and Stage I have 5-year survival above 90% with surgery alone. Stage II ranges 70–85% with surgery ± adjuvant chemo. Stage III with full adjuvant therapy reaches 60–75%. Stage IV with limited liver-only or lung-only metastases that can be resected can still reach 30–50% 5-year survival with multimodal treatment. The plan and the realistic outcome are written down at consultation — we don't promise what we can't deliver, and we don't withhold what's still possible.
What are the early warning signs of colon cancer?
Persistent change in bowel habit (constipation or diarrhoea lasting more than 2–3 weeks), rectal bleeding or blood mixed in stool, narrowing of stools (pencil-thin), unexplained iron-deficiency anaemia, persistent abdominal cramping or bloating, unexplained weight loss, or a feeling that the bowel doesn't fully empty. These are not always cancer — most are benign — but anyone over 45 with these symptoms (or younger with a family history) should have a colonoscopy. Catching colon cancer early changes the outlook completely.
Who is at higher risk for colon cancer in India?
Age over 45, family history of colorectal cancer or polyps, personal history of inflammatory bowel disease (Crohn's, ulcerative colitis), Lynch syndrome or FAP (inherited polyposis), Type-2 diabetes, obesity, sedentary lifestyle, high red/processed meat intake, smoking, heavy alcohol use, and chronic constipation. Importantly, in India and South Asia we are seeing a rising trend of colon cancer in patients under 50 — anyone with persistent symptoms should not be reassured by age alone.
Should I get a second opinion before colon cancer surgery?
Yes — and many CION patients come specifically for a second opinion. Most colon cancers allow 7–14 working days for panel review without compromising outcomes. We re-read your colonoscopy report and slides, re-check your CT and CEA, run molecular profiling if it hasn't been done, give you a written recommendation, and send your records back if you choose to proceed elsewhere. The second opinion is free and there is no pressure to start treatment with us. Acute complications (bleeding, obstruction, perforation) of course need same-day action — call us 24/7.
How quickly can I start colon cancer treatment at CION after diagnosis?
Consultation within 24–48 hours of booking. Complete diagnostic workup (colonoscopy with biopsy if not done, staging CT, CEA, molecular profiling) within 5–7 working days. Panel-vetted plan ready by Day 7–10. Surgery scheduled within 2–3 weeks for elective cases. Obstructing or bleeding tumours are admitted same-day and stabilised first — diverting stoma or stent, then definitive surgery. Adjuvant chemotherapy starts within 4–8 weeks after surgery, in line with NCCN timing.
Take the next step today.
Free consultation. Free written second opinion. NCCN-protocol care across 9 centres in Hyderabad and 35+ partner centres across Telangana & AP. ArogyaSri, CGHS, ECHS and all major insurance accepted.
A multidisciplinary colon cancer team is one phone call away.
1800 202 8726